FindTrial
Sign In

Effect of ulinastatin on inflammation-related factors and early postoperative cognitive function in elderly diabetic patients

Effect of ulinastatin on inflammation-related factors and early postoperative cognitive function in elderly diabetic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015205
Enrollment
Unknown
Registered
2018-03-14
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

U group:ulinastatin
Control group:without intervene

Sponsors

Shunde Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age=65 years, with type 2 diabetes, ASA I-III, patients with gastric cancer or colon cancer and all patients had a clear awareness and fluent language in preoperative

Exclusion criteria

Exclusion criteria: Refuse to participate; Without regular treatment of poorly controlled hypertension;MMSE score<23; Serious hepatic or renal dysfunction; Cardiovascular disease or dysfunction of blood coagulation; Related drug allergies

Design outcomes

Primary

MeasureTime frame
MMSE score;S100ß;IL-6;IL-10;TNF-a;—

Countries

China

Contacts

Public ContactXing Zumin

Shunde Hospital of Southern Medical University

13923260368@163.com+86 13923260368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026